Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe

Autor: Hofman, P., Calabrese, F., Kern, I., Adam, J., Alarcão, A., Alborelli, I., Anton, N.T., Arndt, A., Avdalyan, A., Barberis, M., Bégueret, H., Bisig, B., Blons, H., Boström, P., Brcic, L., Bubanovic, G., Buisson, A., Caliò, A., Cannone, M., Carvalho, L., Caumont, C., Cayre, A., Chalabreysse, L., Chenard, M.P., Conde, E., Copin, M.C., Côté, J.F., D’Haene, N., Dai, H.Y., de Leval, L., Delongova, P., Denčić-Fekete, M., Fabre, A., Ferenc, F., Forest, F., de Fraipont, F., Garcia-Martos, M., Gauchotte, G., Geraghty, R., Guerin, E., Guerrero, D., Hernandez, S., Hurník, P., Jean-Jacques, B., Kashofer, K., Kazdal, D., Lantuejoul, S., Leonce, C., Lupo, A., Malapelle, U., Matej, R., Merlin, J.L., Mertz, K.D., Morel, A., Mutka, A., Normanno, N., Ovidiu, P., Panizo, A., Papotti, M.G., Parobkova, E., Pasello, G., Pauwels, P., Pelosi, G., Penault-Llorca, F., Picot, T., Piton, N., Pittaro, A., Planchard, G., Poté, N., Radonic, T., Rapa, I., Rappa, A., Roma, C., Rot, M., Sabourin, J.C., Salmon, I., Prince, S. Savic, Scarpa, A., Schuuring, E., Serre, I., Siozopoulou, V., Sizaret, D., Smojver-Ježek, S., Solassol, J., Steinestel, K., Stojšić, J., Syrykh, C., Timofeev, S., Troncone, G., Uguen, A., Valmary-Degano, S., Vigier, A., Volante, M., Wahl, S.G.F., Stenzinger, A., Ilié, M.

Publikováno v: In ESMO Open October 2023 8(5)

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Mécanismes de résistance aux inhibiteurs de BRAF

Autor: Charles, J., Martel, C., de Fraipont, F., Leccia, M.-T., Robert, C., Busser, B.

Publikováno v: In Annales de dermatologie et de venereologie November 2014 141(11):671-681

PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France project

Autor: Blons, H., Oudart, J.-B., Merlio, J.-P., Debieuvre, D., De Fraipont, F., Audigier-Valette, C., Escande, F., Hominal, S., Bringuier, P-P, Fraboulet-Moreau, S., Ouafik, L., Moro-Sibilot, D., Lemoine, A., Langlais, A, Missy, P., Morin, F., Souquet, P.-J., Barlesi, F., Cadranel, J., Beau-Faller, M, Bringuier, P.‐P., Beau‐Faller, M.

Publikováno v: Lung Cancer
Lung Cancer, Elsevier, 2021, 151, pp.69-75. ⟨10.1016/j.lungcan.2020.11.008⟩
Lung Cancer, 2021, 151, pp.69-75. ⟨10.1016/j.lungcan.2020.11.008⟩

Objectives Tumor mutation screening is standard of care for patients with stage IV NSCLC. Since a couple of years, widespread NGS approaches used in routine diagnostics to detect driver mutations such as EGFR, KRAS, BRAF or MET allows the identificat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9824b05c3c221a34bd2d0313e01a2b7
https://doi.org/10.1016/j.lungcan.2020.11.008

Étude de la méthylation des GST dans la salive en cas de cancer des VADS

Autor: Righini, C.A., de Fraipont, F., Timsit, J.-F., Dassonville, O., Milano, G., Moro-Sibilot, D.

Publikováno v: In Revue de Stomatologie et de Chirurgie Maxillo-faciale 2008 109(4):226-232